Korean Circ J.  2019 Sep;49(9):838-840. 10.4070/kcj.2019.0236.

Thrombus in Left Ventricle, Is This a Game Changer or a Marker of Disease?

• Choi JO

• KMID: 2455789
• DOI: http://doi.org/10.4070/kcj.2019.0236

Abstract

No abstract available.

MeSH Terms

Heart Ventricles*
Thrombosis*

Reference

1. Kim MS, Lee JH, Kim EJ, et al. Korean guidelines for diagnosis and management of chronic heart failure. Korean Circ J. 2017; 47:555–643.

2. Habash F, Vallurupalli S. Challenges in management of left ventricular thrombus. Ther Adv Cardiovasc Dis. 2017; 11:203–213.

3. Friberg L, Rosenqvist M, Lip GY. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J. 2012; 33:1500–1510.

4. Chiarella F, Santoro E, Domenicucci S, Maggioni A, Vecchio C. Predischarge two-dimensional echocardiographic evaluation of left ventricular thrombosis after acute myocardial infarction in the GISSI-3 study. Am J Cardiol. 1998; 81:822–827.

5. Son JW, Park WJ, Choi JH, et al. Abnormal left ventricular vortex flow patterns in association with left ventricular apical thrombus formation in patients with anterior myocardial infarction: a quantitative analysis by contrast echocardiography. Circ J. 2012; 76:2640–2646.

6. Oh JK, Park JH, Lee JH, Kim J, Seong IW. Shape and mobility of a left ventricular thrombus are predictors of thrombus resolution. Korean Circ J. 2019; 49:829–837.

7. Stratton JR, Resnick AD. Increased embolic risk in patients with left ventricular thrombi. Circulation. 1987; 75:1004–1011.

8. Lee GY, Song YB, Hahn JY, et al. Anticoagulation in ischemic left ventricular aneurysm. Mayo Clin Proc. 2015; 90:441–449.

9. Melgaard L, Gorst-Rasmussen A, Lane DA, Rasmussen LH, Larsen TB, Lip GY. Assessment of the CHA₂DS₂-VASc score in predicting ischemic stroke, thromboembolism, and death in patients with heart failure with and without atrial fibrillation. JAMA. 2015; 314:1030–1038.

10. Greenberg B, Neaton JD, Anker SD, et al. Association of rivaroxaban with thromboembolic events in patients with heart failure, coronary disease, and sinus rhythm: a post hoc analysis of the COMMANDER HF trial. JAMA Cardiol. 2019; 4:515–523.